The Discounted Cash Flow (DCF) valuation of West Pharmaceutical Services Inc (WST) is 230.38 USD. With the latest stock price at 276.40 USD, the upside of West Pharmaceutical Services Inc based on DCF is -16.7%.
Based on the latest price of 276.40 USD and our DCF valuation, West Pharmaceutical Services Inc (WST) is a sell. selling WST stocks now will result in a potential gain of 16.7%.
| Range | Selected | |
| WACC / Discount Rate | 7.6% - 10.2% | 8.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 162.83 - 418.56 | 230.38 |
| Upside | -41.1% - 51.4% | -16.7% |